Status:
UNKNOWN
Shiatsu Adjuvant Therapy And Placebo For Schizophrenia
Lead Sponsor:
Herzog Hospital
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the current study we will study the effect of adding acupressure (shiatsu) to conventional therapy in treating individuals with schizophrenia.
Detailed Description
Acupressure, also known as shiatsu, is a holistic form of medicine originating in Japan but now widely practiced throughout the world. The theory is based on Traditional Chinese Medicine (TCM), which ...
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder
- Ages 18 and over
- Clinical status stable, as reflected by changes in Brief Psychiatric Rating Scale (BPRS) (Overall \& Gorham, 1961) of less than 20% during a one month period prior to randomization, and at least one month of drug treatment without change of anti-psychotic drug or dosage.
- Ability to cooperate with 40-minute sessions
Exclusion
- Unstable general medical conditions
- Active bone fracture or other orthopedic problem
- Skin condition that renders treatment unsafe or painful
- Active infection in skin or soft tissues, such as cellulitis
- Solid tissue malignancy
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00788970
Start Date
January 1 2009
End Date
December 1 2011
Last Update
January 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herzog Hospital, Department of Psychiatry
Jerusalem, Israel, 91351